Ying Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ying Zhu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Chun-E Wang
College of Pharmacy and Life Science, Jiujiang University, Jiujiang, Jiangxi, China
1 shared publication- Deyue Yu
National Key Laboratory of Crop Genetics and Germplasm Enhancement, National Center for Soybean Improvement Nanjing Agricultural University Nanjing China
1 shared publication Hao Cheng
National Center for Soybean Improvement, National Key Laboratory of Crop Genetics and Germplasm Enhancement, Nanjing Agricultural University, Nanjing, Jiangsu, China
1 shared publicationHuairen Zhang
National Center for Soybean Improvement, National Key Laboratory of Crop Genetics and Germplasm Enhancement, Nanjing Agricultural University, Nanjing, Jiangsu, China
1 shared publicationJiao Wang
National Center for Soybean Improvement, National Key Laboratory of Crop Genetics and Germplasm Enhancement, Nanjing Agricultural University, Nanjing, Jiangsu, China
1 shared publication- Shanshan Chu
Collaborative Innovation Center of Henan Grain Crops, College of Agronomy, Henan Agricultural University , Zhengzhou 450046
1 shared publication
Latest Publications
- Open Access
- 10 May 2017
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 13 (5) , e1006770
An R2R3-type MYB transcription factor, GmMYB29, regulates isoflavone biosynthesis in soybean
Isoflavones comprise a group of secondary metabolites produced almost exclusively by plants in the legume family, including soybean [Glycine max (L.) Merr.]. They play vital roles in plant defense and have many beneficial effects on human health. Isoflavone content is a complex quantitative trait controlled by multiple genes, and the genetic mechanisms underlying isoflavone biosynthesis remain largely unknown. Via a genome-wide association study (GWAS), we identified 28 single nucleotide polymorphisms (SNPs) that are significantly associated with isoflavone concentrations in soybean. One of these 28 SNPs was located in the 5’-untranslated region (5’-UTR) of an R2R3-type MYB transcription factor, GmMYB29, and this gene was thus selected as a candidate gene for further analyses. A subcellular localization study confirmed that GmMYB29 was located in the nucleus. Transient reporter gene assays demonstrated that GmMYB29 activated the IFS2 (isoflavone synthase 2) and CHS8 (chalcone synthase 8) gene promoters. Overexpression and RNAi-mediated silencing of GmMYB29 in soybean hairy roots resulted in increased and decreased isoflavone content, respectively. Moreover, a candidate-gene association analysis revealed that 11 natural GmMYB29 polymorphisms were significantly associated with isoflavone contents, and regulation of GmMYB29 expression could partially contribute to the observed phenotypic variation. Taken together, these results provide important genetic insights into the molecular mechanisms underlying isoflavone biosynthesis in soybean. Isoflavones are bioactive substances with various benefits, and increasing isoflavone content is one of the major aims of soybean quality improvement. Isoflavone biosynthesis is regulated by multiple genes and complex metabolic networks. The modification of certain structural genes in the isoflavone pathway by genetic engineering has been unable to significantly improve isoflavone content. Thus, the identification and application of transcription factors specific to the isoflavone pathway may effectively resolve this problem. Here, a genome-wide association study (GWAS) was used to identify an R2R3-type MYB transcription factor, GmMYB29, associated with soybean isoflavone contents. Transient expression and plant transformation results confirmed that GmMYB29 positively regulates isoflavone biosynthesis in soybean. A candidate-gene association analysis identified 11 probable causative GmMYB29 polymorphisms. The identification and functional characterization of GmMYB29 not only improves our understanding of the genetic molecular mechanisms underlying isoflavone synthesis but also provides a direct target for both genetic engineering and selection for the improvement of isoflavone content in soybean.
- 10 May 2017
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 13 (5) , e1006770
Open AccessAn R2R3-type MYB transcription factor, GmMYB29, regulates isoflavone biosynthesis in soybean
Isoflavones comprise a group of secondary metabolites produced almost exclusively by plants in the legume family, including soybean [Glycine max (L.) Merr.]. They play vital roles in plant defense and have many beneficial effects on human health. Isoflavone content is a complex quantitative trait controlled by multiple genes, and the genetic mechanisms underlying isoflavone biosynthesis remain largely unknown. Via a genome-wide association study (GWAS), we identified 28 single nucleotide polymorphisms (SNPs) that are significantly associated with isoflavone concentrations in soybean. One of these 28 SNPs was located in the 5’-untranslated region (5’-UTR) of an R2R3-type MYB transcription factor, GmMYB29, and this gene was thus selected as a candidate gene for further analyses. A subcellular localization study confirmed that GmMYB29 was located in the nucleus. Transient reporter gene assays demonstrated that GmMYB29 activated the IFS2 (isoflavone synthase 2) and CHS8 (chalcone synthase 8) gene promoters. Overexpression and RNAi-mediated silencing of GmMYB29 in soybean hairy roots resulted in increased and decreased isoflavone content, respectively. Moreover, a candidate-gene association analysis revealed that 11 natural GmMYB29 polymorphisms were significantly associated with isoflavone contents, and regulation of GmMYB29 expression could partially contribute to the observed phenotypic variation. Taken together, these results provide important genetic insights into the molecular mechanisms underlying isoflavone biosynthesis in soybean. Isoflavones are bioactive substances with various benefits, and increasing isoflavone content is one of the major aims of soybean quality improvement. Isoflavone biosynthesis is regulated by multiple genes and complex metabolic networks. The modification of certain structural genes in the isoflavone pathway by genetic engineering has been unable to significantly improve isoflavone content. Thus, the identification and application of transcription factors specific to the isoflavone pathway may effectively resolve this problem. Here, a genome-wide association study (GWAS) was used to identify an R2R3-type MYB transcription factor, GmMYB29, associated with soybean isoflavone contents. Transient expression and plant transformation results confirmed that GmMYB29 positively regulates isoflavone biosynthesis in soybean. A candidate-gene association analysis identified 11 probable causative GmMYB29 polymorphisms. The identification and functional characterization of GmMYB29 not only improves our understanding of the genetic molecular mechanisms underlying isoflavone synthesis but also provides a direct target for both genetic engineering and selection for the improvement of isoflavone content in soybean.